£202.30

Springer Recent Advances and Challenges in the Treatment of Major Depressive Disorder (Advances in Experimental Medicine and Biology, 1456)

Price data last checked 17 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£202 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical
Generating forecast…
£249.99 £197.53 £208.98 £220.42 £231.87 £243.31 £254.76 16 June 2026 04 July 2026 22 July 2026 09 August 2026 28 August 2026

Price Distribution

Price distribution over 74 days • 2 price levels

Days at Price
Current Price
1 day · current 73 days 0 18 37 55 73 £202 £250 Days at Price

Price Analysis

Most common price: £250 (73 days, 98.6%)

Price range: £202 - £250

Price levels: 2 different prices over 74 days

Description

This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 September 2025
Listed Since
10 October 2025

Barcode

No barcode data available